Dayondon, Johara .
HRN: 20-87-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2025
METRONIDAZOLE 500MG (TAB)
07/17/2025
07/24/2025
PO
500mg
1 Tab TID X 7 Days
Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes